Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.
    Difference
    11%
    Check dated 2025-10-06T05:30:59.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:04:19.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1. The Back to Top link has been removed.
    Difference
    0.7%
    Check dated 2025-09-14T19:25:39.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T16:17:54.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    22%
    Check dated 2025-08-31T12:04:03.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:23:53.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.